CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

CENTRAL LABORATORIES APPLICATIONS & STUDIES

CENTRAL LABORATORIES PRODUCTS & SERVICES

The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.

Change how you compete by getting the clinical data services and support you need. Medrio is here to help clinical trial sponsors and CROs build internal expertise and support any clinical trial data management needs.

Experience higher data quality, retention and participant compliance by providing a truly engaging experience from data submission to reminders, appointment management, telemedicine and more -- from the phone, tablet, or desktop.

Shape crucial market choices and value substantiation with the depth and breadth of integrated clinical EHRs, claims, and patient reported outcome data, backed by analytical and therapy area expertise.

Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.

Elevate Your Clinical Research Data Collection

A global team of trusted experts for multi-phase clinical development.

Navigating drug safety in the era of innovation-driven medicine

The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.